Aphena Pharma Solutions, a pharmaceutical services provider, has reportedly announced the continuous expansion of its Tennessee-based Solid Dose Division worth $21 million. This division is expected to be completed by 1st April 2021.
The expansion, announced in September 2020, includes the takeover of a 500,000-sq.ft. property that was purpose-built for the manufacturing & packaging operations of the FDA. It also represents the expansion of Aphena into biologics, 3rd-party logistics distribution, and cold chain storage, with 47,000-sq.ft. of the cold chain storage currently available.
The latest progress has enabled Aphena to further expand its bottle packaging capacity with the initial installation of 10 high-speed bottling lines for solid-based products such as gel caps, soft gels, caplets, capsules, and tablets. The company is further planning to install 30 more high-speed lines in this new facility in the future, boosting its monthly capacity to nearly 80 million bottles as well as becoming a strategic partner in the industry for pharmaceutical solid dose packaging.
The turnkey bottling services of Aphena include purchasing all the primary & secondary packaging materials such as pharmaceutical bottle labeling with the serialization support. Various configurations and sizes like square bottles are also available. In addition, the company has the capability to efficiently run batches of over 1,000 to 10 million bottles under the cGMP quality systems.
According to Eric Allen, EVP of Sales & Marketing at Aphena, the new facility and bottling lines have set the foundation for the future of the company’s solid dose packaging, enabling it to maintain a capacity level of 50% for new projects as well as surge the capacity requirements to increasingly cater to the customers’ needs.
Aphena Pharma is an industry-leading company that provides contract manufacturing & packaging services for the medical device, consumer health, pharmaceutical, and biologics markets. The company, with two FDA- and DEA-registered U.S. locations, handles suspensions, foams, ointments, creams, gels, liquids, solid dose, and lotion-based products.
Source credit:
Email: [email protected] 
Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...
The ODP Corporation, an American retail company, has recently announced the expansion of its long-standing relationship with Microsoft. The two companies are planning to boost efficiencies and growth of their shared as...
Ascletis Pharma Inc.’s wholly-owned company, Gannex, has reportedly announced the positive clinical data from its ASC41 trial conducted among overweight and obese subjects. The active metabolite of this liver-tar...
© 2021 news.marketsizeforecasters.com. All Rights Reserved.